Rebecca Whelan featured in Bench to Bedside Podcast
Prof. Whelan's interview for the Bench to Bedside podcast is now live! Hear from our very own Professor Rebecca Whelan on the science behind ovarian cancer detection in a recent episode of the Bench to Bedside podcast.
The University of Kansas Cancer Center’s podcast Bench to Bedside provides a glimpse into the latest research discoveries that are transforming cancer care. Join Roy Jensen, MD, vice chancellor and director of the cancer center, weekly to hear from the top experts in the field as well as patients and caregivers.
In this episode of Bench to Bedside, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, sits down with Dr. Rebecca Whelan, an associate professor of chemistry at the University of Kansas and member of KU Cancer Center’s Cancer Biology research program. The discussion focuses on the limitations of the CA125 blood test for ovarian cancer detection and Dr. Whelan’s groundbreaking research, which reveals new insights into the structure of the CA125 protein. Dr. Whelan explains how new DNA sequencing technologies and artificial intelligence, specifically the Alpha Fold program, have helped her team improve the understanding and detection of ovarian cancer. Additionally, Dr. Whelan talks about collaborative efforts to identify new biomarkers for early diagnosis of ovarian cancer and shares advice for young scientists interested in making a difference in medicine through chemistry.
You can listen to the full podcast, Episode 43 - Cracking the Code: Research Sheds New Light on Ovarian Cancer Biomarker:
https://www.kucancercenter.org/news-room/podcasts
Learn more about Dr. Whelan’s research into CA125